Part,  Chapter, Paragraph

 1    I,     3.  3    |       importance when considering the financing of long-term care.~ ~These
 2   II,     5.  7.  7|          Health Care Organization and Financing for renal replacement therapy
 3   II,     5. 14.  2|        private and public health care financing agencies, and decision-makers
 4   II,     9.  3.  2|              even lower. Legislation, financing (public/private insurance/
 5   IV,    11.  1.  1|     dimensions: generating resources; financing; providing services; and
 6   IV,    11.  1.  1|         encompass health status, fair financing, and responsiveness. While
 7   IV,    11.  1.  1|              provision, resources and financing of health systems in the
 8   IV,    11.  1.  1|            The last part examines the financing of health care, including
 9   IV,    11.  1.  1|               expenditure, sources of financing, progressiveness of funding
10   IV,    11.  1.  2|              areas such as sources of financing, waiting times, provider
11   IV,    11.  1.  3|              through a combination of financing and organization characteristics.
12   IV,    11.  1.  3|           population, and fairness of financing. The report further delineates
13   IV,    11.  1.  3|       provision, resource generation, financing and stewardship. One of
14   IV,    11.  1.  4|            2003) (see Section 11.6 on Financing health care). Organizational
15   IV,    11.  1.  6|             outcomes of health system financing. Specifically, these payment
16   IV,    11.  1.  6|             even when implemented for financing purposes, their objectives
17   IV,    11.  1.  6|               objectives reach beyond financing to other aims such as increased
18   IV,    11.  1.  6|            impact of the DRG hospital financing systems introduced in Europe
19   IV,    11.  1.  6|          regulation (see Section 11.6 Financing Health Care). In the Central
20   IV,    11.  1.  6|           have embarked on healthcare financing reforms, the separation
21   IV,    11.  2.  1|               characteristics such as financing, resource allocation and
22   IV,    11.  3    |               factors relating to the financing, organization, regulation
23   IV,    11.  3.  2|         heavily on private sources of financing. Public expenditure on pharmaceuticals
24   IV,    11.  6    |                                 11.6. Financing healthcare~ ~This section
25   IV,    11.  6.  1|           options of pursuing deficit financing (not a realistic option
26   IV,    11.  6.  2|              and assessment of health financing systems~ ~Health financing
27   IV,    11.  6.  2|            financing systems~ ~Health financing consists of three main functions:
28   IV,    11.  6.  2|              affecting the three main financing functions – such as changes
29   IV,    11.  6.  2|               the basis of the health financing goals outlined by the WHO:
30   IV,    11.  6.  2|       financial protection, equity in financing, equity of access, transparency
31   IV,    11.  6.  2|             was a shift away from tax financing to employment related insurance
32   IV,    11.  6.  2|           achieve the goals of health financing. Finally, the definition
33   IV,    11.  6.  2|     Collecting funds~ ~The sources of financing include individuals or households
34   IV,    11.  6.  2|        countries, the role of private financing has increased over the last
35   IV,    11.  6.  2|              minor role in healthcare financing in Europe, although it appears
36   IV,    11.  6.  2|       payments represent an important financing source in many countries (
37   IV,    11.  6.  2|            Key reforms to the overall financing systems in Europe have been
38   IV,    11.  6.  2|               to the system of health financing was also seen in the Netherlands,
39   IV,    11.  6.  2|       insurance funds.~ ~Table 11.12. Financing mix separated by public
40   IV,    11.  6.  2|              of indirect taxes in the financing system thus has a significant
41   IV,    11.  6.  2|           fact a large driver for the financing reforms in France in the
42   IV,    11.  6.  2|      significant changes to the Dutch financing system. This Law replaces
43   IV,    11.  6.  3|               One study of healthcare financing in OECD countries found
44   IV,    11.  6.  3|            more progressive system of financing than local taxation. For
45   IV,    11.  6.  3|         insurance, this will make the financing system more progressive,
46   IV,    11.  6.  3|          change in progressiveness of financing in the transition countries
47   IV,    11.  6.  3|              be estimated that health financing in this region has become
48   IV,    11.  6.  3|             of fairness of healthcare financing. This formula is based on
49   IV,    11.  6.  3|                Thus, a fair system of financing would be one where the ratio
50   IV,    11.  6.  3|              country with the fairest financing system appears to be Slovakia,
51   IV,    11.  6.  4|      maintained in theory, inadequate financing and informal payments have
52   IV,    11.  6.  5|       distributional impact of health financing in Europe: a review. Oxford,
53   IV,    11.  6.  5|          Federation (2006): DRGs as a financing tool. Brussels, HOPE.~ ~
54   IV,    11.  6.  5| distributional changes in health care financing in Finland." Journal of
55   IV,    11.  6.  5|               M et al. (2002): Health financing reforms in central and Eastern
56   IV,    11.  6.  5|            HTA in the European Union. Financing Sustainable Healthcare in
57   IV,    12.  5    |    utilisation~Health expenditure and financing~Health care quality/performance~ ~
58   IV,    13.  5    |           share of private sources of financing must not hinder accessibility
59   IV,    13.  5    |       Measures include changes in the financing mechanisms, but secure financing
60   IV,    13.  5    |      financing mechanisms, but secure financing of long-term care is yet
61  Key,   Ap5.  0.  0|       fibrosis~filariasis~filoviridae~financing~Finland~fish~flavourings~